NYLI Healthy Hearts ETF
HART
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 51 Madison Avenue New York NY United States of America 10010
- IPO Date
- Jan 14, 2021
- Website
- newyorklifeinvestments.com
- Similar Companies
- Business
- NYLI Healthy Hearts ETF (HART) is an exchange-traded fund that seeks to track the performance of the NYLI Candriam Healthy Hearts Index, providing exposure to global companies supporting cardiovascular health through prevention and treatment initiatives; these include firms involved in diagnosis and treatment of cardiovascular disease, manufacturing and distribution of healthy food or wellness products, services for health information access and heart-healthy choices, and fitness tracking solutions for active lifestyles. The ETF holds approximately 69 securities, with top holdings such as Novartis AG, Pfizer Inc., UnitedHealth Group Inc., Abbott Laboratories, and Eli Lilly and Company, emphasizing a thematic ESG focus within the healthcare sector targeting institutional and retail investors seeking social impact alongside returns. Launched on January 14, 2021, by New York Life Investments, a division of New York Life Insurance Company founded in 1845 and headquartered in New York City, the fund operates globally with an expense ratio of 0.45% and assets under management of around $9 million as of mid-2025. In a significant recent development, New York Life Investments announced on June 26, 2025, plans to liquidate the NYLI Healthy Hearts ETF, with trading ceasing and creation/redemption orders halting after market close on August 19, 2025, and proceeds distributed to shareholders on or about August 26, 2025. This strategic change reflects ongoing portfolio adjustments by New York Life Investments, which manages over $754 billion in assets and maintains affiliations with the American Heart Association's Social Impact Fund stemming from the ETF's original 2021 launch in partnership with IndexIQ.